Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $2.02 Million - $2.3 Million
-6,799 Reduced 82.58%
1,434 $464,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $571,675 - $671,230
2,051 Added 33.18%
8,233 $2.67 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $635,540 - $789,815
-2,708 Reduced 30.46%
6,182 $1.77 Million
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $3.74 Million - $4.65 Million
-16,650 Reduced 65.19%
8,890 $2.46 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $2.17 Million - $2.67 Million
9,786 Added 62.12%
25,540 $5.9 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $7.72 Million - $9.99 Million
-42,764 Reduced 73.08%
15,754 $3.62 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $7.9 Million - $10.2 Million
48,061 Added 459.61%
58,518 $10.9 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $1.64 Million - $2.17 Million
-12,544 Reduced 54.54%
10,457 $1.77 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $1.88 Million - $2.17 Million
12,836 Added 126.28%
23,001 $3.41 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $2.23 Million - $2.69 Million
-16,380 Reduced 61.71%
10,165 $1.67 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $2.9 Million - $3.59 Million
24,345 Added 1106.59%
26,545 $3.68 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $1.44 Million - $1.78 Million
-13,475 Reduced 85.96%
2,200 $289,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $5.91 Million - $6.43 Million
-55,353 Reduced 77.93%
15,675 $1.75 Million
Q2 2019

Aug 12, 2019

BUY
$110.79 - $129.32 $7.6 Million - $8.87 Million
68,609 Added 2836.25%
71,028 $7.87 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $198,243 - $233,346
-1,781 Reduced 42.4%
2,419 $314,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $444,780 - $498,288
4,200 New
4,200 $486,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.